DoD Kideny Cancer, Technology Development Award

The summary for the DoD Kideny Cancer, Technology Development Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
DoD Kideny Cancer, Technology Development Award: The KCRP Technology Development Award is a product-driven award mechanism intended to advance the development of technologies to aid kidney cancer clinical and patient outcomes, including prevention, detection, diagnosis, treatment, or quality of life. Applicants with limited kidney cancer experience are strongly encouraged to collaborate with those having substantial expertise in kidney cancer research and/or kidney cancer model systems. Applications must describe how the technology will enhance the existing knowledge of kidney cancer. The product(s) to be developed may be a tangible item such as a pharmacologic agent (drugs or biologics) or device. The Principal Investigator (PI) must provide a transition plan (including potential funding and resources) showing how the product will progress to the next level of development (e.g., clinical trials, delivery to the military or civilian market) after the completion of the KCRP award. Applications must include preliminary data relevant to the proposed phase of development (data does not have to be in kidney cancer). Informative clinical data from a related human disease may be used to support the rationale for the proposed study. These data may be unpublished and/or from the published literature. Investigators seeking to identify a product should consider submitting to the FY18 KCRP Concept Award (W81XWH-18-KCRP-CA) or the FY18 KCRP Idea Development Award (W81XWH-18-KCRP-IDA), as appropriate. Examples of the types of research that may be supported include, but are not limited to: Use of artificial intelligence to identify novel targets for kidney cancer therapy and/or biomarkers of response/resistance to therapeutics. Platform development or adaptation to provide ultrasensitive, multiplexed detection of genomic, proteomic, and metabolic biomarkers to determine renal cell carcinoma (RCC) molecular phenotype and/or disease status from a single biological sample (e.g., tissue, blood, urine). Technology application to enable dissemination of accurate and up-to-date kidney cancer information to patients and caregivers. Development of a virtual annotated tumor bank that may be used by the research community as a resource to study molecular characteristics, disease status, population demographics, etc. Licensing and Commercialization Partners: Applicants are encouraged to identify and foster relationships with potential licensing and commercialization partners early in the development process. Biotechnology or pharmaceutical companies intending to apply for the Therapeutic Development Award are encouraged to leverage their own resources to complement the funding provided by this award. Participating organizations should ensure the success of the collaboration by resolving potential intellectual and material property issues and by removing organizational barriers that might interfere with achieving high levels of cooperation. Letters confirming/supporting the collaboration are required. The anticipated direct costs budgeted for the entire period of performance for an FY18 KCRP Technology Development Award will not exceed $300,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information. The proposed research must be relevant to active duty Service members, Veterans, military beneficiaries, and/or the American public.
Federal Grant Title: DoD Kideny Cancer, Technology Development Award
Federal Agency Name: Dept of the Army USAMRAA (DOD-AMRAA)
Grant Categories: Science and Technology
Type of Opportunity: Discretionary
Funding Opportunity Number: W81XWH-18-KCRP-TDA
Type of Funding: Cooperative Agreement
CFDA Numbers: 12.420
CFDA Descriptions: Information not provided
Current Application Deadline: September 26th, 2018
Original Application Deadline: September 26th, 2018
Posted Date: June 8th, 2018
Creation Date: June 8th, 2018
Archive Date: October 26th, 2018
Total Program Funding: $1,920,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards: 4
Cost Sharing or Matching: No
Last Updated: June 8th, 2018
Applicants Eligible for this Grant
Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
Grant Announcement Contact
CDMRP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org

CDMRP Help Desk
Similar Government Grants
DoD Combat Readiness - Rapid Development and Translational Research Award
DoD Reconstructive Transplant Research Program, Qualitative Research Award
DoD Chronic Pain Management Research Program, Translational Research Award
DoD Chronic Pain Management Research Program, Investigator-Initiated Research Award
DoD Complex Traumatic Brain Injury Rehabilitation Research - Clinical Research Award
FY2006 Deployed War Fighter Protection Research Program
Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
More Grants from the Dept of the Army USAMRAA
DoD Combat Readiness - Rapid Development and Translational Research Award
DoD Reconstructive Transplant Research Program, Qualitative Research Award
DoD Chronic Pain Management Research Program, Translational Research Award

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com